Suchergebnisse - "Brown, Jennifer R"

PubPharm (447)

101

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia

enthalten in: Blood advances | 2020

von Kim, H. | Shaughnessy, C. | Rai, S. | +14

102

Outcomes of COVID-19 in patients with CLL : a multicenter international experience

enthalten in: Blood | 2020

von Mato, A. | Roeker, L. | Lamanna, N. | +59

CommentIn: Blood. 2020 Sep 3;136(10):1115-1116. - PMID 32882019

103

Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents

enthalten in: Blood advances | 2020

von Roeker, L. | Dreger, P. | Brown, J. | +22

104

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

enthalten in: HemaSphere | 2020

von Rossi, D. | Shadman, M. | Condoluci, A. | +8

105

Inverting the BTK-BCL2 order

enthalten in: Blood | 2020

von Brown, J.

CommentOn: Blood. 2020 Jun 18;135(25):2266-2270. - PMID 32244251

106

Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors

enthalten in: Blood advances | 2020

von Ryan, C. | Cheng, M. | Issa, N. | +2

107

ALPINE : zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

enthalten in: Future oncology (London, England) | 2020

von Hillmen, P. | Brown, J. | Eichhorst, B. | +9

108

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia : updated phase 2 results

enthalten in: Blood | 2020

von Byrd, J. | Wierda, W. | Schuh, A. | +22

109

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

enthalten in: Blood advances | 2020

von Merryman, R. | Edwin, N. | Redd, R. | +21

110

For CLL cells, there's no place like home

enthalten in: Leukemia & lymphoma | 2019

von Lampson, B. | Brown, J.

CommentOn: Leuk Lymphoma. 2019 Dec;60(14):3461-3469. - PMID 31352850